Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Idarucizumab reversed dabigatran completely and rapidly in study

    July 11, 2017

    One drug reversed the anticoagulant effect of another completely and rapidly.

  • News

    Amplatzer devices outperform oral anticoagulation in atrial fib

    July 7, 2017

    PARIS – Greater net clinical benefit documented in registry.

  • 1
    News

    FDA approves betrixaban for VTE prophylaxis

    June 23, 2017

    An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.

  • 1
    News

    Rest dyspnea dims as acute heart failure treatment target

    June 19, 2017

    PARIS – Results from two new acute heart failure trials “mark the start of a new era.”

  • 1
    News

    HFrEF mortality halved when treatment matches guidelines

    June 14, 2017

    PARIS – Full adherence to heart failure guidelines works.

  • News

    Angiotensin II may improve vasopressors’ efficacy

    June 14, 2017

    Adding a certain hormone could strengthen treatment options for vasodilatory shock patients.

  • 1
    News

    Assessing the risks associated with MRI patients with a pacemaker or defibrillator

    June 13, 2017

    What are the risks of nonthoracic MRI in patients with pacemakers or implantable cardioverter-defibrillators (ICD) who are not preapproved by the Food and Drug Administration for MRI scanning?

  • 1
    News

    Atrial fibrillation blunts beta-blockers for HFrEF

    June 11, 2017

    Do beta-blockers alter mortality in HFrEF with atrial fib??

  • 1
    News

    Low-dose aspirin bests dual-antiplatelet therapy in TAVR

    June 8, 2017

    PARIS – ARTE trial is hailed as practice changing.

  • 1
    News

    A prescription for heart failure success: Change the name

    June 5, 2017

    PARIS – This condition’s very name dooms it to failure. Dr. Lynne Warner Stevenson has some ideas to fix that.

Previous1 … 68 69 70 71 72 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences